About this trial
Severe obstructive jaundice caused by pancreatic head cancer usually requires preoperative biliary drainage, but its necessity and effectiveness are controversial, and specific strategies lack clear standards. This study proposed a new strategy for preoperative biliary drainage using serum prealbumin as the main evaluation index, and compared it with the traditional strategy using serum total bilirubin as the main evaluation index. Through a randomized, controlled, multicenter prospective study, we explored the effects of different drainage strategies on the incidence of in-hospital complications and long-term prognosis of patients with resectable pancreatic head cancer, guided clinical decisions on preoperative drainage time and surgical timing, and provided high-quality evidence-based medicine for preoperative biliary drainage of pancreatic head cancer.
Eligibility criteria
Qualifiers
Pathological diagnosis of pancreatic head cancer, or clinical diagnosis of pancreatic head cancer after multidisciplinary discussion, clear presence of obstructive jaundice caused by pancreatic head tumor, and planned to undergo radical pancreaticoduodenectomy
Preoperative imaging stage is resectable
Baseline serum total bilirubin ≥ 250μmol/L, and no history of preoperative biliary drainage
Age >18 and ≤75 years old
Disqualifiers
Combined with other malignant tumors
Combined with uncontrolled medical diseases or organ dysfunction and other absolute counterindications for surgery
Pregnant and lactating women
Patients who cannot tolerate preoperative biliary drainage or radical surgery
Trial design
Treatments tested in this trial
- Modified strategy
- Traditional strategy